CSI Medical Research. Incorporated in 2017. Our growth has doubled each year in terms of team size and revenue. We have set up an office in Malaysia in 2020, amidst the pandemic and will open an Australia entity by 2022.
Great customer experiences, and thus we have a good proportion of returning customers. These customers do not see us as vendors but partners that can work together to achieve their objectives!
On delivering clinical trials within Asia Pacific, a region we call home.
Extensive knowledge of local workflows and regulations, combined with our industry experience enabling us to provide high quality and cost-effective services tailored to your needs.
To be a recognizable SEA CRO brand by 2025.
• To uphold and protect patient safety in our clinical trials.
• To provide modular, cost-effective solutions, customized to our clients’ clinical needs.